Does EVOLOCUMAB Cause Anaemia? 118 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 118 reports of Anaemia have been filed in association with EVOLOCUMAB (REPATHA). This represents 0.1% of all adverse event reports for EVOLOCUMAB.
118
Reports of Anaemia with EVOLOCUMAB
0.1%
of all EVOLOCUMAB reports
2
Deaths
53
Hospitalizations
How Dangerous Is Anaemia From EVOLOCUMAB?
Of the 118 reports, 2 (1.7%) resulted in death, 53 (44.9%) required hospitalization, and 4 (3.4%) were considered life-threatening.
Is Anaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVOLOCUMAB. However, 118 reports have been filed with the FAERS database.
What Other Side Effects Does EVOLOCUMAB Cause?
Device difficult to use (31,807)
Drug dose omission by device (23,957)
Wrong technique in product usage process (21,664)
Accidental exposure to product (16,160)
Injection site pain (9,988)
Product storage error (6,606)
Back pain (5,254)
Myalgia (5,061)
Drug dose omission (4,914)
Injection site bruising (4,409)
What Other Drugs Cause Anaemia?
LENALIDOMIDE (5,322)
CARBOPLATIN (5,312)
RIBAVIRIN (5,130)
ASPIRIN (4,568)
CYCLOPHOSPHAMIDE (4,486)
RITUXIMAB (4,399)
DEXAMETHASONE (4,352)
ADALIMUMAB (3,994)
PACLITAXEL (3,949)
METHOTREXATE (3,913)
Which EVOLOCUMAB Alternatives Have Lower Anaemia Risk?
EVOLOCUMAB vs EXELON
EVOLOCUMAB vs EXEMESTANE
EVOLOCUMAB vs EXENATIDE
EVOLOCUMAB vs EXFORGE
EVOLOCUMAB vs EXJADE